At AHA’s Urging, DEA Takes Steps to Address IV Opioid Shortages

Apr 06, 2018 - 03:23 PM
iv-opioid-shortage

At the request of AHA and others, the Drug Enforcement Administration has taken steps that will address the IV opioid shortages. DEA recently granted some additional quota for raw materials to West-Ward Pharmaceuticals and Fresenius Kabi USA so that they can produce certain injectable opioid medications that are experiencing severe shortages. The Food and Drug Administration has updated its drug shortage database to reflect the upcoming availability of these products. Both drug companies will continue work with DEA on additional quota requests to try to accommodate hospitals’ supply needs for these products in the upcoming months. On Feb. 27, the AHA and several other national pharmacy, medical, and safety organizations sent DEA a letter urging the agency to temporarily adjust the aggregate production quotas for injectable opioid medications in short supply to allow other manufacturers to supply product until the shortages resolve. For more information about how to access these products, the FDA’s database includes customer service contact information for these and other drug companies. The AHA this week shared with hospitals and health systems a new resource developed by the American Society of Health-System Pharmacists and the University of Utah Drug Information Service with suggestions for managing the injectable opioid shortages.

Related News Articles

Chairperson's File
Chair File: Leadership Dialogue — The Role of Advocacy in Advancing Health Care with AHA Executive Vice President Stacey Hughes
Public
We’re at a watershed moment in health care, which gives us opportunities to strengthen how we serve patients and communities. Health care leaders must help…
Perspective
Hospitals Are Leading the Way to a Healthier America
Public
This week, more than 1,000 hospital and health system leaders came to Washington, D.C., united by a shared responsibility: to ensure every community has access…
Chairperson's File
Chair File: Supporting and Sharing the Healing Work of Hospitals and Their Care Teams
Public
More than 1,000 leaders from hospitals and health systems across the country will gather in Washington, D.C., early next week at the 2026 AHA Annual…
Headline
Webinar to share strategies on workforce relief 
The AHA will host a webinar April 16 at 1 p.m. ET featuring leaders from CHRISTUS Health and The Urology Group to share how nurse-first triage and smarter…
Headline
Mississippi 340B law upheld by appeals court in two cases
The U.S. Court of Appeals for the 5th Circuit April 9 affirmed rulings by a Mississippi district court that rejected requests by Novartis and PhRMA to enjoin…
Perspective
At AHA’s Annual Membership Meeting, Uniting to Protect Access to Care
Public
Just 23 days from now, more than 1,000 hospital and health system leaders from across the country will arrive in Washington, D.C., for the 2026 AHA Annual…